Manufacturing and Mass Balance of Copper Phthalocyanine (CPC) Blue and Green Pigments

Authors

  • Dr. Ashok K Rathoure Eco Group of Companies
  • Savita Goyal Aggarwal Dept. of Chemistry, GRD Institute of Management and Technology, 12, Rajpur Road, Dehradun, Uttarakhand, India.

Keywords:

CPC Green, Beta Blue, Ink, Manufacturing, Textile, Tint

Abstract

Organic pigments are cost-effective, non-toxic, and possess good color strength, which makes them good choice for their use across various end-use sectors. Copper phthalocyanine (CPC) blue is the copper (II) complex of tetra aza tetra benzoporphine (CPC) whereas phthalocyanine green is its chlorinated derivative. The brominated derivatives of CPC provide a yellowish green shade. The specific crystal modification decides the hue of the product as in Alpha Blue-red shade copper phthalocyanine (Pigment Blue 15) and in Beta Blue-green shade blue (Pigment Blue 15:3). CPC Blue is an upstream product and is a raw material used for the manufacture of our Pigment Blue and Pigment Green products. CPC Blue is also sold to other manufacturers of pigments including a related party for the manufacture of textile dyestuffs. Here we have presented the manufacturing process of two organic pigments – CPC Green and Blue.

References

1. Sandor S, Prelipceanu O, Checiu I. Sulphonated phthalocyanine induced caudal malformative syndrome in the chick embryo. Morphol Embryol (Bucur) 1985; 31(3): 173-81.
2. OECD SIDS. Copper Phthalocyanine. CAS N°:147-14-8. 1990. Available online at http://www.inchem.org/documents/sids/sids/147148.pdf.
3. Rathoure AK, Aggarwal SG. Manufacturing process with chemical reactions and mass balance for 6 pharmaceutical drugs. J Durg Dis Dev 2017; 1(1): 54-64.

Downloads

Published

2018-10-27

How to Cite

Rathoure, D. A. K., & Aggarwal, S. G. (2018). Manufacturing and Mass Balance of Copper Phthalocyanine (CPC) Blue and Green Pigments. Journal of Drug Discovery and Development ( ISSN:2581-6861), 2(1), 18-23. Retrieved from https://medicaljournalshouse.com/index.php/JDrug-Discovery-Development/article/view/60

Issue

Vol. 2 No. 1 (2018): Journal of Drug Discovery and Development

Section

Research Article

License

We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-

1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.

2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.

3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.

4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.

5. I/We also agree to the authorship of the article in the following sequence:-

Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________

Important

(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.

(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.

(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.